Vise Technologies Inc. purchased a new stake in Corteva, Inc. (NYSE:CTVA – Free Report) during the second quarter, Holdings Channel.com reports. The institutional investor purchased 22,135 shares of the company’s stock, valued at approximately $1,875,000.
A number of other hedge funds also recently made changes to their positions in the stock. E Fund Management Co. Ltd. bought a new position in shares of Corteva during the second quarter worth about $210,000. Bell & Brown Wealth Advisors LLC bought a new stake in Corteva in the second quarter valued at approximately $1,231,000. Johnson Financial Group Inc. acquired a new stake in Corteva during the 2nd quarter valued at approximately $63,000. Tocqueville Asset Management L.P. acquired a new stake in Corteva during the 2nd quarter valued at approximately $843,000. Finally, NewEdge Wealth LLC bought a new position in Corteva during the 2nd quarter worth approximately $1,253,000. 81.54% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
CTVA has been the topic of a number of recent analyst reports. Rothschild & Co Redburn boosted their price target on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. CICC Research increased their price objective on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Mizuho lifted their target price on shares of Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 14th. Barclays upped their price target on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research report on Thursday, June 11th. Finally, BMO Capital Markets increased their price target on Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, August 3rd. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $91.50.
Corteva Price Performance
Corteva stock opened at $81.84 on Friday. The stock has a market capitalization of $54.60 billion, a price-to-earnings ratio of 54.20, a PEG ratio of 2.44 and a beta of 0.57. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $90.97. The stock’s 50 day moving average price is $82.13 and its two-hundred day moving average price is $80.21. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52.
Corteva (NYSE:CTVA – Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. During the same quarter in the previous year, the business posted $2.20 EPS. Corteva’s revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.
Corteva Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s payout ratio is 47.68%.
Corteva Company Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Stories
- Five stocks we like better than Corteva
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
